Media Coverage

Long COVID: A ‘massive disabling event’

Seattle Times columnist Naomi Ishisaka spoke with ISB President Dr. Jim Heath about why long COVID is such a hard problem to solve.

Posted:
The Seattle Times
Long COVID: A ‘massive disabling event’

The new science of wellness

In this special report, Scientific American explores how the emerging field of phenomics is merging modern science and technology with ancient and modern ways to keep people healthy to harness health-related data to stop disease before it starts.

Posted:
Scientific American
The new science of wellness

COVID infection during pregnancy: What are the risks?

Forbes highlights the ISB-led Lancet paper showing the impact of COVID-19 infection on birth outcomes.

Posted:
Forbes
COVID infection during pregnancy: What are the risks?

COVID in the maternity ward

ISB-led research published in The Lancet showing the impact of COVID-19 infection on birth outcomes was highlighted in this story by CBS News.

Posted:
CBS News
COVID in the maternity ward

The new clues about who will develop long COVID

ISB President Dr. Jim Heath spoke with reporter Sumathi Reddy about the four predictive factors of long COVID.

Posted:
The Wall Street Journal
The new clues about who will develop long COVID

New research hints at 4 factors that may increase chances of long COVID

The New York Times’ Pam Belluck talks with ISB President Dr. Jim Heath about his research showing the four predictive factors of long COVID.

Posted:
The New York Times
New research hints at 4 factors that may increase chances of long COVID

Study suggests microbiome could be key to losing weight

This FOX News story cites ISB research showing that an individual’s gut microbiome affects if he or she can lose weight.

Posted:
FOX News
Study suggests microbiome could be key to losing weight

Second Opinion: The path toward an Alzheimer's cure may not be a drug

In this guest column for The Los Angeles Times, ISB Co-founder and Professor Dr. Lee Hood shares his personal and professional experience with Alzheimer’s disease.

Posted:
The Los Angeles Times
Second Opinion: The path toward an Alzheimer’s cure may not be a drug
1 8 9 10 11